Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study

Robert Landewé, Joachim Sieper, Philip Mease, Robert D. Inman, Robert G. Lambert, Atul Deodhar, Helena Marzo-Ortega, Marina Magrey, Uta Kiltz, Xin Wang, Mei Li, Sheng Zhong, Nael M. Mostafa, Apinya Lertratanakul, Aileen L. Pangan, Jaclyn K. Anderson

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study'. Together they form a unique fingerprint.

Medicine & Life Sciences